Literature DB >> 11713453

Phenotype, ovarian function, and growth in patients with 45,X/47,XXX Turner mosaicism: implications for prenatal counseling and estrogen therapy at puberty.

J Blair1, J Tolmie, A S Hollman, M D Donaldson.   

Abstract

OBJECTIVE: Our objective was to determine whether girls with the rare Tur-ner 45,X/47,XXX mosaic karyotype are less severely affected than girls with 2 commoner karyotypes. STUDY
DESIGN: We evaluated growth status, phenotype, and ovarian function in 7 girls with 45,X/47,XXX mosaicism, age-matching each with 2 girls with 45,X and 1 with 45,X/46,Xi(X)(q10) karyotypes.
RESULTS: For the index, 45,X, and 45,X/46,Xi(X)(q10) groups, respectively, the median/mean height SD score at the start of growth hormone therapy/comparable age was -2.0 (-1.2), -2.3 (-2.4), and -2.6 (-2.6), cardiac anomalies were identified in 0 of 7, 4 of 14, and 1 of 7, renal abnormalities in 0 of 7, 4 of 14, and 3 of 7, middle ear problems in 2 of 7, 11 of 14, and 4 of 7, and special educational needs in 0 of 7, 3 of 14, and 1 of 7. Complete spontaneous puberty with menarche was seen in all but 1 girl older than 12 years in the index group compared with only 1 girl in the comparison groups. Ovarian tissue was identified in 6 of 7, 0 of 14, and 1 of 7 girls, and the mean follicle-stimulating hormone was 6, 25, and 21 U/L, respectively.
CONCLUSION: Girls with 45,X/47,XXX karyotype are mildly affected, with good preservation of ovarian function. This result has important implications for prenatal counseling and the need for estrogen therapy at puberty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713453     DOI: 10.1067/mpd.2001.118571

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Optimising management in Turner syndrome: from infancy to adult transfer.

Authors:  M D C Donaldson; E J Gault; K W Tan; D B Dunger
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

2.  Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.

Authors:  Emma Jane Gault; Rebecca J Perry; Tim J Cole; Sarah Casey; Wendy F Paterson; Peter C Hindmarsh; Peter Betts; David B Dunger; Malcolm D C Donaldson
Journal:  BMJ       Date:  2011-04-14

3.  45,X/47,XXX Mosaicism and Short Stature.

Authors:  Erica Everest; Laurie A Tsilianidis; Anzar Haider; Douglas G Rogers; Nouhad Raissouni; Bahareh Schweiger
Journal:  Case Rep Pediatr       Date:  2015-06-07

4.  Measured parental height in Turner syndrome-a valuable but underused diagnostic tool.

Authors:  Yasmine Ouarezki; Filiz Mine Cizmecioglu; Chourouk Mansour; Jeremy Huw Jones; Emma Jane Gault; Avril Mason; Malcolm D C Donaldson
Journal:  Eur J Pediatr       Date:  2017-12-18       Impact factor: 3.183

Review 5.  Ovarian reserve evaluation in a woman with 45,X/47,XXX mosaicism: A case report and a review of literature.

Authors:  Ruiyi Tang; Lin Lin; Zaixin Guo; Haiyan Hou; Qi Yu
Journal:  Mol Genet Genomic Med       Date:  2019-05-08       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.